Role of Oral Steroid Alone Versus Oral Steroid Plus Intratympanic Steroid Injection in Bell's Palsy

ConditionBell Palsy
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorAssiut University

About this trial

intratympanic steroid injection bell's palsy

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Mean Aged 18 years or more.

Acute unilateral facial palsy without skin lesions which developed within a 72-hour period and is present for 21 days or less.

Moderate to severe facial palsy [House-Brackmann grade IV or greater]

Disqualifiers

Another cause of facial nerve paralysis that is not idiopathic.

Otologic disease including otitis media, temporal bone fracture, a previous history of facial nerve palsy in either side, history of otologic surgery, and suspected Ramsay Hunt syndrome.

Systemic disease including history of tuberculosis, history of head and neck cancer, other neurological disorders, recent use of ototoxic medications, liver or renal dysfunction, and other illnesses that would contraindicate the use of high-dose steroid therapy.

Pregnancy

Trial design

Design model

Parallel

Treatments tested in this trial

  • Corticosteroid

    Drug

    Oral steroids plus intratympanic injection

Treatment groups

42 Participants
are divided into 2 treatment groups
Group A: Oral steroidsActive comparator 1 intervention
Group B: Oral steroids plus intratympanic injectionsActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Success or failure of procedure to treat Bell's palsy

Degree of regaining function to facial nerve Unit of measurement : nerve conduction study Measurement tool :endoscopic injection by ear microscope

Time frame
6 months

Secondary outcomes

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: